Jordan L. Doman

Jordan L. Doman

Auto-generated profile, based on publicly available information

Jordan L. Doman

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
QLQiupeng Lin
Qiupeng Lin
YZYuan Zong
Yuan Zong
CXChenxiao Xue
Chenxiao Xue
SWShengxing Wang
Shengxing Wang
SJShuai Jin
Shuai Jin
CGCaixia Gao
Caixia Gao

10 February 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JDJordan L. Doman
Jordan L. Doman
ARAditya Raguram
Aditya Raguram
GNGregory Newby
Gregory Newby
DLDavid R. Liu
David R. Liu

28 June 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LKLuke W. Koblan
Luke W. Koblan
MAMandana Arbab
Mandana Arbab
MSMax W. Shen
Max W. Shen
JHJeffrey A. Hussmann
Jeffrey A. Hussmann
AAAndrew V. Anzalone
Andrew V. Anzalone
DLDavid R. Liu
David R. Liu

17 May 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
BSBenjamin J. Steinbeck
Benjamin J. Steinbeck
XGXin D. Gao
Xin D. Gao
AMAmber N. McElroy
Amber N. McElroy
SPSmriti Pandey
Smriti Pandey
JDJordan L. Doman
Jordan L. Doman
Mark OsbornMark Osborn
Mark Osborn

18 October 2023 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LKLuke W. Koblan
Luke W. Koblan
MAMandana Arbab
Mandana Arbab
MSMax W. Shen
Max W. Shen
JHJeffrey A. Hussmann
Jeffrey A. Hussmann
AAAndrew V. Anzalone
Andrew V. Anzalone
DLDavid R. Liu
David R. Liu

5 June 2026 in bioRxiv
Verified
Preprint
Open access
NMNader Morshed
Nader Morshed
MDMatthew Demers
Matthew Demers
AGAna Gonzalez-Ramos
Ana Gonzalez-Ramos
HJHenna Jäntti
Henna Jäntti
JDJordan Doman
Jordan Doman
BSBeth Stevens
Beth Stevens
Astrocytes play essential roles in neuronal development, function, and disease, yet existing methods to derive astrocytes from human pluripotent stem cells (hPSCs) are complex and can involve months of in vitro maturation. We developed a genomic safe-harbor knock-in system for inducible expression of the astrogenic transcription factors NFIA, NFIB, and SOX9, enabling rapid and robust generation of functional induced astrocytes (iAstrocytes). Across five hPSC lines, NFIB-SOX9 and NFIA-NFIB-SOX9 combinations efficiently generated highly pure populations expressing astrocyte-specific and synaptogenic genes. iAstrocytes displayed cytokine-induced expression of complement factors C3 and C4 and were amenable to CRISPR interference (CRISPRi) gene expression knockdown. Optimization of culture conditions enabled survival of NFIB-SOX9 iAstrocytes in co-culture with human induced neurons (iNeurons). Through pharmacological and genetic perturbations, we uncovered a previously undescribed phenomenon in which co-culture with iAstrocytes promoted the development of synchronized iNeuron network calcium activity mediated by specific gap junction proteins. This rapid and genetically tractable iAstrocyte platform provides a robust model to dissect human genetic and environmental effects on astrocyte-neuron interactions.